FDA Names Peptide Panel With Industry Ties Ahead of July Review
The panel includes doctors and pharmacists with financial ties to peptide sellers as it reviews seven injectable drugs.
- On Monday, the Food and Drug Administration released its participant list for a July meeting reconsidering seven peptide injections, appointing clinicians and pharmacists with financial ties to the industry instead of traditional academic experts.
- Health Secretary Robert F. Kennedy Jr. reorganized advisory processes to advance his 'Make America Healthy Again' movement, replacing academic-heavy groups that previously deemed these peptide ingredients too risky for patient use.
- Panelists include Dr. Haleem Mohammed of Gameday Men's Health and Dr. Gabriel Alizaidy, who charges $500 for consultations, alongside Tennessee state senator Bobby Harshbarger, a pharmacist at Premiere Pharmacy.
- The FDA has warned for years about risks of injecting chemicals like BPC-157 and TB-500, which lack extensive human study and are often sold online as unapproved wellness treatments.
- This shift follows Kennedy's firing of the Centers for Disease Control and Prevention's 17-member vaccine panel last year, setting a precedent for moving away from traditional scientific oversight toward industry-aligned experts.
40 Articles
40 Articles
FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports
For the latest stories on the science of healthy living, subscribe to NPR’s Health newsletter.While Health Secretary Robert F. Kennedy Jr. pushes to loosen restrictions on a handful of trendy peptide therapies, scientists who work under him are recommending the opposite.On Monday, the Food and Drug Administration posted documents outlining concerns about a lack of evidence for the batch of peptides that are set to be considered by an FDA panel i…
U.S. FDA panel on peptides will include experts who promote the unproven chemicals favoured by RFK Jr.
When U.S. health officials meet next month to reconsider a list of controversial peptide drugs, they will hear from a new set of voices: doctors and pharmacists with deep financial ties to the burgeoning industry of unproven chemicals.
Associated Press News
FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
The Food and Drug Administration is meeting next month to consider easing restrictions on several peptides, a group of unapproved drugs popular with followers of Robert F.
Coverage Details
Bias Distribution
- 48% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
